ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 107124 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 107124; 2) Community: the network communities that were significantly associated with the response to NSC 107124; 3) Molecule: the relationships between components within communities and NSC 107124; 4) MDR: the compounds that were significantly associated with the NSC 107124.

NSC Compound Enrichment Correlation
NSC 654830 4-Amino-4-deoxy-10-ethyl-10-deazapteroyl-.gamma.-methylene glutamic acid 0.00322389497932885 0.24700788
NSC 675253 Null 0.00322389497932885 0.24497362
NSC 682765 5H-Pyrido[3,2-d][2]benzazepin-6(7H)-one, 2-(4-chlorophenyl)-4-phenyl- 0.00322389497932885 0.013696788
NSC 638066 Null 0.00386716420081295 0.36261835
NSC 139105 Soluble Baker's Antifol 0.00423163567577551 0.40506591
NSC 269721 Androstan-3-one, 17-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (5.alpha.,17.beta.)- 0.00423163567577551 0.53801401
NSC 681646 Camptothecin Derivative 0.00423163567577551 0.88148039
NSC 740 Methotrexate 0.00423163567577551 0.45987504
NSC 763059 Paracymene-ruthenium(II)-[N-(3-(1H-imidazol-1-yl)propyl)-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8 tetrahydronaphthalen-2-yl)vinyl)benzamide] dichloride 0.00423163567577551 0.1205557
NSC 128635 Null 0.00550789647802199 0.16734261
Total:72  Current:8    [First] [Prev] [Next] [Last]